Exempts substance use disorder and mental health treatment services and FDA approved medications from recipient restriction program coverage and.
New York S07984 amends the social services law to exempt covered substance use disorder and mental health treatment services and all FDA approved medications for the treatment of substance use disorder, HIV, hepatitis C, and mental health conditions from all recipient restriction program coverage and payment restrictions. This ensures that Medicaid managed care plans cannot restrict these services and medications for members of the recipient restriction program without additional restrictions, edits, authorizations, or referral requirements.
Included in complete analysis
- Overview
- Core Provisions
- Implementation
- Impact
- Legal Framework
- Critical Issues
See what it does, who it affects, and the critical issues in plain language. Free, 30 seconds.